The authors thank our patients for their participation; Kathryn Leeder for her inspiration, Pamela West for her editorial support; Dr Daniel Santa Mina and Dr Paul Oh for advice and guidance; and Dr Soran Abdulkarim, Dr Dina El-Sahrigy, Dr Allan Hunt, Dr Helena Meskel, Dr Bassem Moussa, and Dr Ron Stead for their work on the β-catenin staining. The authors alone are responsible for the content and writing of the article.

Continue Reading


Dr George Dranitsaris owns and is a consultant for Augmentium Pharma Consulting, Inc. The authors report no other conflicts of interest in this work. 

James A. Chiarotto,1 Riyad Akbarali,2 Lara Bellotti,George Dranitsaris3

1Department of Medicine, 2Department of Cardiac Rehabilitation, Scarborough and Rouge Hospital, 3Augmentium Pharma Consulting, Inc., Toronto, ON, Canada 


1. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2010;11:CD006145.

2. Markes M, Brokow T, Resch K. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2009;4:CD005001.

3. Betof AS, Dewhirst MW, Jones LW. Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun. 2013;30(Suppl):S75–S87.

4. Bouillet T, Bigard X, Brami C, et al. Role of physical activity and sport in oncology scientific commission of the National Federation Sport and Cancer CAMI. Crit Rev Oncol Hematol. 2015;94(1):74–86.

5. Schmitz KH, Courneya KS, Matthews C, et al; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–1426.

6. Balducci L, Mo M, Abella E, Saven A. Retrospective analysis of relative dose intensity in patients with non-Hodgkins lymphoma receiving CHOP-based chemotherapy and pegfilgrastim. Am J Clin Oncol. 2014;37(6):603–610.

7. Friedenreich CM, Neilson HK, Farris MS, Courneya KS. Physical activity and cancer outcomes: a precision medicine approach. Clin Cancer Res. 2016;22(19):4766–4775.

8. Morikawa T, Kuchiba A, Yamauchi M, et al. Association of CTNNBI (B-Catenin)alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA. 2011;305(16):1685–1694.

9. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579.

10. Mota DD, Pimenta CA, Piper B. Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised. Support Care Cancer. 2009;17(6):645–652.

11. Kohne C, Cunningham D, Di Costanzo F, et al. Clinical determinants of survival in patients with 5-fluorouracil based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol. 2002;13(2):308–317.

12. Foltran L, De Maglio G, Pella N, et al. Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol. 2015;11(4):629–640.

13. Ligibel JA, Giobbie-Hurder A, Shockro L, et al. Randomized trial of physical activity intervention in women with metastatic breast cancer. Cancer. 2016;122(8):1169–1177.

14. Chasen M, Bhargava R, MacDonald N. Rehabilitation for patients with advanced cancer. CMAJ. 2014;186(14):1071–1075.

15. Lowe SS, Wantanabe SM, Courneya KS. Physical activity as supportive care intervention in palliative care: a systematic review. J Support Oncol. 2009;7(1):27–34.

16. Adamsen L, Quist M, Midtgaard J, et al. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer. 2006;14(2):116–127.

17. Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339:b3410.

18. Oldervoll LM, Loge JH, Lydersen S, et al. Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncologist. 2011;16(11):1649–1657.

19. Coleman EA, Coon S, Hall-Barrow J, Richards K, Gaylor D, Steward B. Feasibility of exercise during treatment for multiple myeloma. Cancer Nurs. 2003;26(5):410–419.

20. Henningsen KH, Desomer A, Hanssens S, Vlayen J. Supportive Treatment for Cancer Part 1: Exercise Treatment. Brussels, Belgium: Belgian Health Care Knowledge Centre (KCE); 2012.

21. Bertheussen GF, Kaasa S, Hokstad S, et al. Feasibility and changes in symptoms and functioning following inpatient cancer rehabilitation. Acta Oncol. 2012;51(8):1070–1080.

22. Kartolo A, Cheng S, Petrella T. Motivation and preferences of exercise programmes in patients with operable metastatic lung cancer: a needs assessment. Support Care Cancer. 2016;24(1):129–137.

23. Jones LW. Precision oncology framework for investigation of exercise as treatment for cancer. J Clin Oncol. 2015;33(35):4134–4137.

24. Rogers L, Hopkins-Price P, Vicari S, et al. A randomized trial to increase physical activity in breast cancer survivors. Med Sci Sports Exerc. 2009;41(4):935–946.

25. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25(28):4396–4404.

26. Sasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW. A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle. 2015;6(2):115–124.

Source: Cancer Management and Research.
Originally published October 13, 2017.